These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29294316)

  • 1. "Who killed JR": Chronic hepatitis C or alcohol use disorders?
    Schwarzinger M; Rehm J; Mallet V
    J Hepatol; 2018 May; 68(5):1098-1099. PubMed ID: 29294316
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "'Who killed JR': Chronic hepatitis C or alcohol use disorders?".
    Alavi M; Law MG; Dore GJ
    J Hepatol; 2018 May; 68(5):1099-1100. PubMed ID: 29292094
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C and alcohol.
    Schiff ER
    Hepatology; 1997 Sep; 26(3 Suppl 1):39S-42S. PubMed ID: 9305662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation on the influence of alcohol on chronic hepatitis C patients].
    Chen J; Wang M; Li YQ; Shen XJ; Zhao WD
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):624-5. PubMed ID: 14572345
    [No Abstract]   [Full Text] [Related]  

  • 5. Is it Possible to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C?
    Ozalper V; Ozturker C; Ozturk E
    J Clin Gastroenterol; 2017 Jan; 51(1):87. PubMed ID: 27533111
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrosis progression in chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Grotto RM; Pardini MI
    Rev Soc Bras Med Trop; 2016; 49(6):806-807. PubMed ID: 28001238
    [No Abstract]   [Full Text] [Related]  

  • 7. New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis.
    Ou P; Li F; Chen J
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1669-1671. PubMed ID: 27329403
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
    Yang J; Rao HY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis.
    Kao WY; Su CW
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1230-1231. PubMed ID: 29574869
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.
    Serfaty L; Chazouillères O; Poujol-Robert A; Morand-Joubert L; Dubois C; Chrétien Y; Poupon RE; Petit JC; Poupon R
    Hepatology; 1997 Sep; 26(3):776-9. PubMed ID: 9303512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to: "High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme".
    Foster GR
    J Hepatol; 2016 Aug; 65(2):448. PubMed ID: 27132169
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the treatment of hepatitis C in 2016].
    Luo BF; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):175-180. PubMed ID: 28482403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Lo GH
    Gastroenterology; 2018 Apr; 154(5):1551. PubMed ID: 29526726
    [No Abstract]   [Full Text] [Related]  

  • 15. Gender Differences in Statin Prescription Rate Among Patients Living With HIV and Hepatitis C Virus.
    Al-Kindi SG; Zidar DA; McComsey GA; Longenecker CT
    Clin Infect Dis; 2016 Oct; 63(7):993-4. PubMed ID: 27369319
    [No Abstract]   [Full Text] [Related]  

  • 16. Cartilage oligomeric matrix protein associates with hepatic inflammation and fibrosis in hepatitis C virus infection.
    Andréasson K; Waldenström J; Westin J; Norrgren H; Jönsson G; Nyström K; Lagging M
    J Hepatol; 2017 Sep; 67(3):649-651. PubMed ID: 28527663
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C.
    Zani C; Pasquale L; Bressanelli M; Puoti M; Paris B; Coccaglio R; Lascioli I; Pieriacci G; Donato F
    Dig Liver Dis; 2011 Aug; 43(8):653-8. PubMed ID: 21530428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.
    Menard A; Aherfi S; Mokhtari S; Dhiver C; Ravaux I; Tissot-Dupont H; Meddeb L; Brouqui P; Stein A; Colson P
    Gut; 2017 Oct; 66(10):1868-1869. PubMed ID: 28073889
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic update in hepatitis C].
    Devesa MJ; Cuenca F; Izquierdo S; Sánchez-Pobre P; Ladero JM; López-Alonso G; Díaz-Rubio M; Rey E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():48-51. PubMed ID: 26365735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.